Top 5 Vendors in the Global Bone Cancer Drugs Market 2019-2023 | Technavio
LONDON–(BUSINESS WIRE)–#Research–The emergence of targeted therapies for the treatment of bone cancer is expected to drive market growth. Currently, targeted…
Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#Research–The emergence of targeted therapies for the treatment of bone cancer is expected to drive market growth. Currently, targeted…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2019 sales…
NEW YORK–(BUSINESS WIRE)–$BMY—Bristol-Myers Squibb Company (NYSE:BMY) announced today that effective July 1, 2019 it has completed its previously announced divestment…
FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to…
Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the efficacy and safety of intravenous (IV) sildenafil when added to inhaled nitric oxide (iNO) for the treatment of newborns with Persistent Pulmonary Hypertension (PPHN) did not meet its primary efficacy endpoint.
Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) today announced that it entered into an amended agreement related to its existing credit facility with SWK Funding LLC
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Psoriatic Arthritis” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the psoriatic…
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health,…
BERWYN, Pa.–(BUSINESS WIRE)–In recognition of the importance of HIV testing and early diagnosis of HIV, AscellaHealth, a specialty-focused pharmaceutical management…
DUBLIN–(BUSINESS WIRE)–The “Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s…